This week, we welcomed our #London interns! We're excited to see the unique contributions each of you will make to our team and look forward to supporting your growth and development during your time with us. #SummerInternship #Consulting #LifeSciences #WelcomeInterns
Putnam
Business Consulting and Services
Boston, MA 24,629 followers
We are an Inizio Advisory company. Bridging Science & Strategy™.
About us
Putnam, an Inizio Advisory company, is a leading scientific and strategic consulting partner that helps the global life science community make confident decisions, build value, and bring life-changing innovations to clinicians and patients. For more than 30 years, our rigorous, bespoke approach and globally diverse team have delivered unrivaled depth across therapeutic areas, business functions, geographic markets, healthcare sectors, and technology platforms to maximize the human impact and commercial success of client innovations.
- Website
-
http://www.putassoc.com/
External link for Putnam
- Industry
- Business Consulting and Services
- Company size
- 201-500 employees
- Headquarters
- Boston, MA
- Type
- Privately Held
- Founded
- 1988
- Specialties
- Strategy Consulting, Biopharmaceutical Consulting, and Life Sciences Consulting
Locations
Employees at Putnam
-
Sarah Pettengill
Manager @ Putnam Associates | Analytics, Operations, and Strategy | Startup Advisor
-
Eric Auger
Partner, Value, Pricing and Access Global Practice Lead at Putnam Associates
-
Amy Costello
Director, Business Operations @ Putnam | Firm Operations Leader
-
Neelesh Chudasama, MD
Updates
-
What does it take for successful AI integration? Sylvaine Barbier, Principal, RWE & Biostatistics shares her perspective on AI adoption in the pharmaceutical industry, including how we can learn from historical transformative innovations and how pharma leaders should consider approaching AI integration. Read now: https://lnkd.in/e-5dca5f #AI #Pharmaceuticals #Pharma #Healthcare #LifeSciences
-
-
Missed our lived webinar? You can still watch the recording to hear HEOR experts, Aurélie Meunier, Director, and Mariia Dronova, Director, delve into the critical topic of health equity. Discover how distributional cost-effectiveness analysis (DCEA) methods can highlight the enhanced value of your assets. Watch now: https://lnkd.in/dmf-Uhuq #HealthEquity #HEOR #DCEA #HTA #Evidence #Value
-
-
Are you interested in learning more about the Life Sciences Consultant position here at Putnam? We're excited to announce for the 2024/2025 Life Sciences Consultant (PhD, MD, PharmD) season, we will be providing the Path to Putnam Information session on demand. Learn more about who we are and what we do as a leading consultancy in the life sciences space, our mission and objectives, and find out some helpful tips for preparing your appliction. Watch the session here: https://lnkd.in/eA2cQME2 #LSC #LifeSciences #Consulting
-
-
Here’s how ClarityNav is helping us deliver clear, actionable medical affairs insights to you faster, helping you to drive your strategies forward. https://lnkd.in/e7CcPcJR #AI #GenAI #Data #Insights #MedicalAffairs #ClarityNav
-
A whole new level of medical insight. With ClarityNav, the newest tool in our InizioNavigator suite, our Medical Affairs experts are able to bring you actionable insights faster and more efficiently than ever before. Find out how here https://lnkd.in/e6CeKpmj #AI #GenAI #Data #Insights #MedicalAffairs #ClarityNav
-
-
You may remember some of the key themes we shared ahead of #ASCO24. Post-congress, our experts are reflecting back on those themes and summarizing the key insights and takeaways on these modalities from ASCO 2024. Read more & get in touch: https://lnkd.in/eHCmAX36 #CancerResearch #ADCs #RadioPharmaceuticals #Bispecifics
-
-
We continue to help clients navigate the complexities surrounding the #InflationReductionAct. Today, our experts are diving into the anticipated effects of the IRA on payer contracting. While the Inflation Reduction Act will lower costs for CMS and patients, it is also likely to cause a range of second-order effects on the pharmaceutical industry, primarily around R&D investments and payer contract dynamics. How should the pharmaceutical industry be preparing for these shifts? Learn more from Thomas Marder, Matthew Riordan, and Scott Briggs in our latest piece here: https://lnkd.in/eXZMa5Xe #Pharma #IRA #Healthcare #Payers
-
-
Some of the key agenda items for tomorrow’s live webinar on health equity and distributional cost-effectiveness analysis: -An introduction to DCEA -Overview of methods -Deep dive into published examples -Q&A discussion See you there! Register now to join live or get access to the recorded session: https://lnkd.in/epZ3KGVq #HealthEquity #HEOR #DCEA #HTA #Evidence #Value
-
-
One week to go! Are you joining our upcoming #webinar, Distributional cost-effectiveness analysis (DCEA): Capturing equity impacts in economic evaluation? Learn more and register now: https://lnkd.in/ehbBV56H #HealthEquity #HEOR #DCEA #HTA #Evidence #Value
-